Wild Times at Perot (JJ that is...)

June 24, 2011
Reports have circulated about a major RIF at Perot in their newly-acquired "JJ Wild" division. As you "Meditechies" all know, JJ Wild was the only

Reports have circulated about a major RIF at Perot in their newly-acquired "JJ Wild" division. As you "Meditechies" all know, JJ Wild was the only officially endorsed "partner" of Meditech for hardware, garnering themselves a handsome annual revenue with little marketing costs - somewhere around $100M per year. Perot's acquisition of them seemed a little strange - what did a premier consulting firm want to sell hardware for? Simple answer - about $100M per year in annual revenue...

There was no official announcement from Perot about the cuts, which impacted mainly senior management at JJ. Unofficially, Perot reps dismiss the cuts as trimming what they felt was a bloated top management level at JJ, which is probably true of most large firms, including Perot! The difference is who's on top at the time of the cuts... What does it mean in the market? Probably not much: most wise buyers ( a small few unfortunately) get quotes directly from IBM, Dell, etc., to keep JJ's bloated quotes honest. The majority of Meditech buyers however do whatever they say in Boston, drinking the magic cool-aid and over-paying substantially for fairly standard servers, plus large add-on "consulting" fees from JJ.

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?